Skip to content

Pharminent

Primary Menu
  • Home
    • Signal News
Light/Dark Button
Brief
  • Home
  • Policy / Pricing
  • Prior Authorization Metrics Provide New Insights into Insurer Practices, but Gaps Remain
  • Policy / Pricing

Prior Authorization Metrics Provide New Insights into Insurer Practices, but Gaps Remain

KFF Medicare

This analysis of available 2025 prior authorization data finds insurers denied at least 1 in 8 standard requests for prior authorization across three insurance markets: Medicare Advantage, Medicaid ma

Read full story

pharminent August 13, 2026 (Last updated: August 14, 2026)

KFF Medicare

This analysis of available 2025 prior authorization data finds insurers denied at least 1 in 8 standard requests for prior authorization across three insurance markets: Medicare Advantage, Medicaid ma

Read full story

Post navigation

Previous: Eli Lilly Files Six Lawsuits to Combat Illegal Retatrutide Black Market
Next: MFN affecting Swiss medicines access, says Interpharma

Related Stories

  • Policy / Pricing

Mid-cap biotechs join Trump’s latest round of drug pricing deals

pharminent September 1, 2026
  • Policy / Pricing

MFN sparks defiance from Europe’s larger nations, uncertainty among smaller ones

pharminent August 27, 2026
  • Policy / Pricing

MFN affecting Swiss medicines access, says Interpharma

pharminent August 13, 2026
  • Home
  • Contact
© 2026 All rights reserved. | ReviewNews by AF themes.